Correction to: GTS-21, an α7nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function
Saved in:
Main Authors: | , , , , , , |
---|---|
Format: | Book |
Published: |
BMC,
2021-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
LEADER | 00000 am a22000003u 4500 | ||
---|---|---|---|
001 | doaj_f17f3de072894c3aa5f2eef3c39c3e64 | ||
042 | |a dc | ||
100 | 1 | 0 | |a Ravikumar A. Sitapara |e author |
700 | 1 | 0 | |a Alex G. Gauthier |e author |
700 | 1 | 0 | |a Vivek S. Patel |e author |
700 | 1 | 0 | |a Mosi Lin |e author |
700 | 1 | 0 | |a Michelle Zur |e author |
700 | 1 | 0 | |a Charles R. Ashby |e author |
700 | 1 | 0 | |a Lin L. Mantell |e author |
245 | 0 | 0 | |a Correction to: GTS-21, an α7nAChR agonist, increases pulmonary bacterial clearance in mice by restoring hyperoxia-compromised macrophage function |
260 | |b BMC, |c 2021-08-01T00:00:00Z. | ||
500 | |a 10.1186/s10020-021-00357-5 | ||
500 | |a 1076-1551 | ||
500 | |a 1528-3658 | ||
546 | |a EN | ||
690 | |a Therapeutics. Pharmacology | ||
690 | |a RM1-950 | ||
690 | |a Biochemistry | ||
690 | |a QD415-436 | ||
655 | 7 | |a article |2 local | |
786 | 0 | |n Molecular Medicine, Vol 27, Iss 1, Pp 1-1 (2021) | |
787 | 0 | |n https://doi.org/10.1186/s10020-021-00357-5 | |
787 | 0 | |n https://doaj.org/toc/1076-1551 | |
787 | 0 | |n https://doaj.org/toc/1528-3658 | |
856 | 4 | 1 | |u https://doaj.org/article/f17f3de072894c3aa5f2eef3c39c3e64 |z Connect to this object online. |